Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2010
07/15/2010WO2010078897A1 Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
07/15/2010WO2010078830A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
07/15/2010WO2010078762A1 8-hydroxyquinoline–based white-light-emitting organic electroluminescent material
07/15/2010WO2010058032A3 Substituted pyrimidines for the treatment of diseases such as cancer
07/15/2010WO2010057101A3 Compounds useful as hiv blockers
07/15/2010WO2010055896A3 Pyridine derivative or its salt, pesticide containing it and process for its production
07/15/2010WO2010045306A3 Azine derivatives and methods of use thereof
07/15/2010WO2010018555A3 Quinoline compounds containing a dibemethin group
07/15/2010WO2009098051A8 Aryl sulfonamides as effective analgesics
07/15/2010US20100179329 Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole suitable for the treatment of abnormal cell growth in mammals
07/15/2010US20100179328 Process for producing sulphoxide compounds
07/15/2010US20100179319 Process for production of optically active mirtazapine
07/15/2010US20100179194 Insecticidal aryl isoxazoline derivatives
07/15/2010US20100179191 Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
07/15/2010US20100179183 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
07/15/2010US20100179176 V3 antagonists for the treatment or prevention of chronic pain
07/15/2010US20100179172 N-phenyl-methanamine derivative and pesticide containing it
07/15/2010US20100179163 Nol3 is a predictor of patient outcome
07/15/2010US20100179161 Pyrazoline derivatives for the treatment of turberculosis
07/15/2010US20100179150 Antibacterial piperdine derivatives
07/15/2010US20100179149 Aryl ether pyridazinone derivatives
07/15/2010US20100179147 Benzimidazole compounds and their use as anticancer agents
07/15/2010US20100179146 Indolinone Compounds as Kinase Inhibitors
07/15/2010US20100179144 Quinazoline derivatives as p13 kinase inhibitors
07/15/2010US20100179141 Novel jnk inhibitors
07/15/2010US20100179140 Indenoisoquinolinone analogs and methods of use thereof
07/15/2010US20100179137 Pyridone compound
07/15/2010US20100179127 Pyrimidine derivatives
07/15/2010US20100179122 Non-Nucleoside Reverse Transcriptase Inhibitors
07/15/2010US20100179118 Cyclic aminoalkylcarboxamide derivative
07/15/2010US20100178710 Mass Labels
07/15/2010US20100178247 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
07/15/2010US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma
07/15/2010CA2749174A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
07/15/2010CA2749012A1 Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
07/15/2010CA2747670A1 Carbazole carboxamide compounds useful as kinase inhibitors
07/15/2010CA2746943A1 Serotonin 5-ht2b receptor inhibitors
07/14/2010EP2206707A1 Azolecarboxamide compound or salt thereof
07/14/2010EP2206704A1 Pharmaceutically active diazepanes
07/14/2010EP2205590A1 Cgrp antagonists
07/14/2010EP2205589A2 C-met protein kinase inhibitors
07/14/2010EP2205588A2 Oxypiperidine derivatives as histamine receptor antagonists
07/14/2010EP2205587A2 Novel compounds
07/14/2010EP2205585A1 Quinoline derivatives used to treat inflammatory and allergic diseases
07/14/2010EP2205584A1 Spiropyrrolidines and their use against hcv and hiv infection
07/14/2010EP2205583A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists
07/14/2010EP2205573A1 Tetrazole-substituted aryl amide derivatives and uses thereof
07/14/2010EP2205564A1 Novel kinase inhibitors
07/14/2010EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
07/14/2010EP2205560A1 Azabicyclo ý3. 1. 0¨hexyl derivatives as modulators of dopamine d3 receptors
07/14/2010EP2205559A1 Renin inhibitors
07/14/2010EP2205558A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
07/14/2010EP2205317A1 Pyridine derivatives for the treatment of amyloid-related diseases
07/14/2010EP2205086A2 Fungicidal heterocyclic amines
07/14/2010EP2024355B1 Alkene piperidine derivatives as antiviral agents
07/14/2010EP1863812B1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
07/14/2010EP1853602B1 Chemical compounds
07/14/2010EP1723138B1 Substituted benzimidazoles and their use for inducing apoptosis
07/14/2010EP1699778B1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics
07/14/2010EP1689721B1 Aminopyrazole derivatives as gsk-3 inhibitors
07/14/2010EP1648443B1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
07/14/2010EP1539141B1 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
07/14/2010CN1823063B Quinoline derivatives as phosphodiesterase inhibitors
07/14/2010CN101778905A Indolium compound and optical recording material using the compound
07/14/2010CN101778838A Azacyclylbenzamide derivatives as histamine-3 antagonists
07/14/2010CN101778837A Pyrrolidine aryl-ether as nk3 receptor antagonists
07/14/2010CN101778831A Novel piperazine amide derivatives
07/14/2010CN101778825A N-heterocyclic compounds useful as inhibitors of janus kinases
07/14/2010CN101775013A Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
07/14/2010CN101775007A Tricyclene compounds with HIV antagonistic activity and preparation method and application thereof
07/14/2010CN101775006A Free radical initiator and method for peptide sequencing using thereof
07/14/2010CN101775005A Cadrofloxacin hydrochloride-I crystal and preparation method thereof
07/13/2010US7754887 Process for production of sulfoxide derivatives or salts thereof in the amorphous state
07/13/2010US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12)
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010US7754742 such as 1-methyl-1H-imidazole-4-carboxylic acid 4-(3-hydroxy-4-isobutyryl-2-trifluoromethyl-phenoxymethyl)-benzylamide; preferential modulatators of glutamate receptors, used as antidepressants and anxiolytic agents
07/13/2010US7754741 nonphytotoxic of N-[2-(3-Chloro-5-trifluoromethyl-pyridin-2-yl) ethyl]-2-trifluoromethyl-nicotinamide, used for controlling phytopathogenic fungi selected from Alternaria and Pyrenophora
07/13/2010US7754740 ethyl 1-benzyl-5-(3-carboxypropoxy)-2-methyl-6-pyrid-3-yl-1H-indole-3-carboxylate; peroxisome proliferator activated receptors agonist; dyslipidaemia, atherosclerosis, diabetes, obesity; high level lipoprotein controllong
07/13/2010US7754738 pyrazolecarboxanilide derivatives such as N-(2-chloro-6-methylphenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide, used for controlling pests; effective, less costly, less toxic and environmentally friendly pesticides
07/13/2010US7754737 such as N-(1-amino-3-cyclohexylpropan-2-yl)-3-(1-hydroxy-1-phenylpentyl)piperidine-1-carboxamide, used in the treatment of cardiovascular, metabolic and cognitive disorders, aldosteronism, hypertension and anxiety
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders
07/13/2010US7754730 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
07/13/2010US7754727 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
07/13/2010US7754724 such as 1-Benzyl-4-[(3,5-dimethylisoxazol-4-yl)carbonyl]piperazine, used for controlling fungi and insects; insecticides; fungicides
07/13/2010US7754723 Therapeutic agents useful for treating pain
07/13/2010US7754722 Piperazine derivatives and methods of use
07/13/2010US7754720 Reacting 5-(6-chloro-pyridazin-3-ylmethyl)-2-(2-fluoro-phenyl)-5H-imidazo(4,5-c)pyridine with 2,4-bis(trifluromethyl)phenylboronic acid in presence of dimethoxyethane; treatment or prophylaxis of hepatitis C
07/13/2010US7754717 Bis-aryl amide compounds and methods of use
07/13/2010US7754716 vatalanib succinate (PTK787) and temozolomide; glioblastomas
07/13/2010US7754714 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers
07/13/2010US7754713 such as 6-(4-Hydroxy-3,5-dimethylphenyl)-4-(7-methyl-1H-benzimidazol-2-yl)-2H-pyridazin-3-one, used as cyclin-dependent kinase inhibitors, for the treatment of cancer, in particular solid tumors or leukemia; anticarcinogenic agents
07/13/2010US7754711 Pyridazine derivatives and their use as therapeutic agents
07/13/2010CA2539546C Isoquinoline potassium channel inhibitors
07/13/2010CA2500888C Isoquinoline compounds and medicinal use thereof
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2427837C Radioactive member for use in brachytherapy and method of making
07/08/2010WO2010078449A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders